2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.
Standard
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. / Bachner, M; Loriot, Y; Gross-Goupil, M; Zucali, P A; Horwich, A; Germa-Lluch, J-R; Kollmannsberger, C; Stoiber, F; Fléchon, A; Oechsle, Karin; Gillessen, S; Oldenburg, J; Cohn-Cedermark, G; Daugaard, G; Morelli, F; Sella, A; Harland, S; Kerst, M; Gampe, J; Dittrich, C; Fizazi, K; De Santis, M.
in: ANN ONCOL, Jahrgang 23, Nr. 1, 1, 01.2012, S. 59-64.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.
AU - Bachner, M
AU - Loriot, Y
AU - Gross-Goupil, M
AU - Zucali, P A
AU - Horwich, A
AU - Germa-Lluch, J-R
AU - Kollmannsberger, C
AU - Stoiber, F
AU - Fléchon, A
AU - Oechsle, Karin
AU - Gillessen, S
AU - Oldenburg, J
AU - Cohn-Cedermark, G
AU - Daugaard, G
AU - Morelli, F
AU - Sella, A
AU - Harland, S
AU - Kerst, M
AU - Gampe, J
AU - Dittrich, C
AU - Fizazi, K
AU - De Santis, M
PY - 2012/1
Y1 - 2012/1
N2 - 2-¹?fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.
AB - 2-¹?fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.
KW - Humans
KW - Male
KW - Sensitivity and Specificity
KW - Retrospective Studies
KW - Positron-Emission Tomography
KW - Glucose-6-Phosphate/analogs & derivatives/diagnostic use
KW - Radiopharmaceuticals/diagnostic use
KW - Seminoma/radionuclide imaging
KW - Testicular Neoplasms/radionuclide imaging
KW - Humans
KW - Male
KW - Sensitivity and Specificity
KW - Retrospective Studies
KW - Positron-Emission Tomography
KW - Glucose-6-Phosphate/analogs & derivatives/diagnostic use
KW - Radiopharmaceuticals/diagnostic use
KW - Seminoma/radionuclide imaging
KW - Testicular Neoplasms/radionuclide imaging
U2 - 10.1093/annonc/mdr052
DO - 10.1093/annonc/mdr052
M3 - SCORING: Journal article
C2 - 21460378
VL - 23
SP - 59
EP - 64
JO - ANN ONCOL
JF - ANN ONCOL
SN - 0923-7534
IS - 1
M1 - 1
ER -